Atorvastatin

CAS 134523-00-5 34 API suppliersSmall Molecule

Overview

Atorvastatin is a statin medication used to prevent cardiovascular disease and manage abnormal lipid levels. It works by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol.

API suppliers (34)

Suppliers of Atorvastatin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India21China2Canada1United States1

Country recorded for 25 of 34 suppliers.

14 of 34 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 34 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (101 approved US products), the latest listed US patent on Atorvastatin expires 7 Jun 2037. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

Cardiovascular DiseasesLipid Metabolism DisordersAtherosclerosis
Verified Supplier Partner

Do you supply Atorvastatin? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.